Menu

Oncología Pediátrica  902107469 Hematología Pediátrica 902089800 Urgencias: +34 639 713 145uop@oncopediatrialopezibor.es

Ensayos Clínicos

 

Ensayos Clínicos

  • Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients.

    Duración: 2012 hasta actualidad. 

  • D3820C00016. A Phase I, Open label, Multicentre Study to Assess the Pharmacokinetics and Safety of Naloxegol in Paediatric Patients Ages > 6 Months to < 18 Years receiving Treatment  with Opioids.

    Duración:  2014 hasta actualidad.

  • XM22-08. An opened labeled randomized active-control multicenter study to evaluate the efficacy, pharmacokinetics, pharmacodynamics safety tolerability and immunogenicity of lipegfilgrastim 100 mcg/Kg body weight in comparation to filgrastim 5 mcg/Kg body weight in pediatric patients diagnosed with Ewing family of tumors or rhabdomyosarcoma receiving chemotherapy. Phase II. 

    Duración: Desde 2015 hasta actualidad.

  • A three month prospective open label study of therapy with fragmin (registered) (dalteparin sodium injection) in children with venous thromboembolism with or without malignancies. 

    Duración: desde Enero 2017 hasta actualidad.

  • LOXO-TRK-15002. A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors.

    Duración: Desde 2016 hasta actualidad.